Roger W. Blamey
#143,986
Most Influential Person Now
Roger W. Blamey's AcademicInfluence.com Rankings
Roger W. Blameyphilosophy Degrees
Philosophy
#7656
World Rank
#10897
Historical Rank
Logic
#4702
World Rank
#6023
Historical Rank

Download Badge
Philosophy
Roger W. Blamey's Degrees
- Doctorate Medicine Stanford University
Why Is Roger W. Blamey Influential?
(Suggest an Edit or Addition)Roger W. Blamey's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005) (6940)
- Tamoxifen for early breast cancer: an overview of the randomised trials (1998) (3764)
- The Nottingham prognostic index in primary breast cancer (2005) (904)
- A prognostic index in primary breast cancer. (1982) (715)
- High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses (2005) (596)
- Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. (2000) (576)
- Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. (2008) (496)
- Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes (2009) (473)
- Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long‐term follow‐up (1992) (471)
- Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. (2001) (422)
- The psychological impact of immediate rather than delayed breast reconstruction. (2000) (421)
- Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. (2002) (334)
- Confirmation of a prognostic index in primary breast cancer. (1987) (316)
- c-erbB-2 oncoprotein expression in primary and advanced breast cancer. (1991) (237)
- Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer. (1996) (221)
- Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer. (1999) (214)
- Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. (2007) (212)
- Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity? (1999) (208)
- Early-onset breast cancer--histopathological and prognostic considerations. (1997) (207)
- Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance. (2006) (207)
- Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. (2008) (206)
- Immunocytochemical localization of fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy (1994) (201)
- Screening interval breast cancers: mammographic features and prognosis factors. (1996) (198)
- Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. (1995) (183)
- Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer. (1990) (170)
- Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. (2013) (169)
- A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. (1995) (167)
- p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein. (1993) (163)
- Factors influencing local recurrence after excision and radiotherapy for primary breast cancer (1989) (162)
- Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? (1995) (159)
- The cosmetic outcome in early breast cancer treated with breast conservation. (1999) (151)
- A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer. (1986) (147)
- Epidermal growth factor receptor expression in breast cancer: Association with response to endocrine therapy (2004) (146)
- Immunocytochemical localization of BCL‐2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy (1994) (146)
- Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. (2006) (146)
- Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up. (1992) (145)
- Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer. (1988) (143)
- Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. (1994) (141)
- Estrogen receptor assay in primary breast cancer and early recurrence of the disease. (1978) (140)
- Histologic Grading of Breast Cancer: Linkage of Patient Outcome with Level of Pathologist Agreement (2000) (137)
- Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer. (2003) (137)
- Relationship between oestrogen-receptor content and histological grade in human primary breast tumours. (1978) (134)
- Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. (1997) (134)
- QUANTITATIVE OESTRADIOL RECEPTOR VALUES IN PRIMARY BREAST CANCER AND RESPONSE OF METASTASES TO ENDOCRINE THERAPY (1981) (129)
- INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis. (2000) (129)
- Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases. (1987) (123)
- Tubular carcinoma of the breast: further evidence to support its excellent prognosis. (2010) (122)
- c-erbB-4 protein expression in human breast cancer (2000) (115)
- Expression of epidermal growth factor receptor in breast carcinoma. (1990) (113)
- The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer. (1986) (109)
- An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. (1991) (105)
- ONCOPOOL - a European database for 16,944 cases of breast cancer. (2010) (103)
- Oestrogen-regulated genes in breast cancer: association of pLIV1 with lymph node involvement. (1994) (103)
- Guidelines on the standards for the training of specialised health professionals dealing with breast cancer. (2007) (102)
- Clinical and histological predictors of contralateral breast cancer. (1999) (102)
- A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer. (1995) (101)
- Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) (2003) (101)
- p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor. (1992) (99)
- RELATIONSHIP OF ŒSTROGEN-RECEPTOR STATUS TO SURVIVAL IN BREAST CANCER (1979) (97)
- A monoclonal antibody, NCRC‐11, raised to human breast carcinoma. 1. Production and immunohistological characterization (1984) (97)
- Invasive lobular carcinomas of the breast--the prognosis of histopathological subtypes. (1989) (96)
- Relationship between primary breast tumor receptor status and patient survival (1980) (95)
- Male breast cancer: pathological and immunohistochemical features. (1997) (94)
- The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast. (2009) (94)
- The prognosis of small primary breast cancers. (1999) (91)
- Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator. (1985) (87)
- Circulating immune complexes in patients with breast cancer. (1977) (87)
- Estradiol induction of retinoic acid receptors in human breast cancer cells. (1993) (87)
- Helix pomatia and Ulex Europeus lectin binding in human breast carcinoma (1987) (87)
- EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival (1998) (86)
- E-cadherin as a prognostic indicator in primary breast cancer (2001) (86)
- A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast. (1991) (84)
- Goserelin depot in the treatment of premenopausal advanced breast cancer. (1992) (83)
- Oestrogen-receptor status and sites of metastasis in breast cancer. (1981) (83)
- Prognostic significance of synchronous and metachronous bilateral breast cancer (2001) (82)
- Cytological grading of breast carcinoma—a feasible proposition? (1990) (81)
- Tumour aneuploidy, prognostic parameters and survival in primary breast cancer. (1987) (80)
- EUSOMA accreditation of breast units. (2006) (76)
- Up‐regulation of the protein tyrosine phosphatase SHP‐1 in human breast cancer and correlation with GRB2 expression (2000) (76)
- Guidelines on endocrine therapy of breast cancer EUSOMA. (2002) (74)
- Immunocytochemical localization of estrogen receptor in human breast tissue. (1988) (74)
- Subcutaneous mastectomy for primary operable breast cancer (1984) (74)
- In situ carcinoma of the breast. (1989) (74)
- Metallothionein expression in human breast cancer. (1995) (73)
- Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer. (1996) (73)
- Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis. (1995) (73)
- Prognostic factors in breast cancer -- the formation of a prognostic index. (1979) (72)
- Cosmetic assessment of breast-conserving surgery for primary breast cancer. (1999) (71)
- Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein. (1993) (70)
- The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers (2010) (69)
- Patient evaluation of cosmetic outcome after conserving surgery for treatment of primary breast cancer. (1999) (68)
- The British Association of Surgical Oncology Guidelines for surgeons in the management of symptomatic breast disease in the UK (1998 revision). BASO Breast Specialty Group. (1998) (65)
- Screening women aged less than 50 years with a family history of breast cancer. (1998) (65)
- A methodology to identify consensus classes from clustering algorithms applied to immunohistochemical data from breast cancer patients (2010) (64)
- The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. United Kingdom Co-ordinating Committee on Cancer Research. (2002) (63)
- A comparison of the use of the ‘Tru‐Cut’ needle and fine needle aspiration cytology in the pre‐operative diagnosis of carcinoma of the breast (1978) (58)
- Reading the prognosis of the individual with breast cancer. (2007) (57)
- Chemotherapy‐induced differential changes in lymphocyte subsets and natural‐killer‐cell function in patients with advanced breast cancer (1993) (55)
- Immunocytochemical investigation of intermediate filament proteins and epithelial membrane antigen in spindle cell tumours of the breast (1988) (52)
- Carcinoma of the breast imaged by nuclear magnetic resonance (NMR). (1979) (52)
- 4. The design and clinical use of the nottingham prognostic index in breast cancer (1996) (51)
- Short-term effects of pure anti-oestrogen ICI 182780 treatment on oestrogen receptor, epidermal growth factor receptor and transforming growth factor-alpha protein expression in human breast cancer. (1996) (50)
- The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology (2009) (50)
- Occult axillary lymph-node micrometastases in breast cancer (1990) (49)
- Heterogeneity of oestrogen receptor expression in normal and malignant breast tissue. (1992) (48)
- Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma. (1987) (47)
- Prognostic significance of serum c-erbB-2 protein in breast cancer patients (2005) (47)
- Timing breast cancer surgery (1991) (45)
- Screening for breast cancer (1994) (45)
- Microdochectomy for single‐duct discharge from the nipple (1988) (45)
- Management of physiological gynaecomastia with tamoxifen. (2004) (45)
- Subcutaneous mastectomy for primary breast cancer and ductal carcinoma in situ. (1997) (44)
- Steroid receptors in early breast cancer: value in prognosis. (1981) (44)
- Results from a seven-year programme of breast self-examination in 89,010 women. (1989) (44)
- MAMMOGRAPHY IN SYMPTOMATIC BREAST DISEASE (1989) (43)
- c-myc oncogene product expression and prognosis in operable breast cancer. (1989) (43)
- Estrogen receptors and breast cancer. (1981) (41)
- Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancer. (1985) (41)
- Survival patterns in hormone treated advanced breast cancer (1986) (40)
- Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118630 in breast and prostate cancer. (1984) (40)
- Loss of Heterozygosity in Bilateral Breast Cancer (2000) (39)
- Differential expression of oestrogen regulated genes in breast cancer. (1995) (38)
- Use of reverse transcription-polymerase chain reaction methodology to detect estrogen-regulated gene expression in small breast cancer specimens. (1997) (37)
- Relationship of oestrogen-receptor status to survival in breast cancer. (1979) (37)
- Calcium excretion (CaE) in metastatic breast cancer (1983) (36)
- Staging breast cancer: role of bone scanning. (1977) (36)
- Prediction of lymph node involvement in breast cancer (1991) (35)
- The increasing importance of chronic rejection as a cause of renal allograft failure (1989) (35)
- Bone scanning: Its lack of value in the follow‐up of patients with breast cancer (1979) (34)
- The late results of renal transplantation and the importance of chronic rejection as a cause of graft loss. (1989) (34)
- Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers. (1986) (34)
- IMMUNE COMPLEXES AND PROGNOSIS OF HUMAN BREAST CANCER (1978) (34)
- The relationship of "high risk" mammographic patterns to histological risk factors for development of cancer in the human breast. (1990) (34)
- Use of older patients as cadaveric kidney donors (1988) (33)
- Preoperative diagnosis in carcinoma of the breast (1977) (33)
- Epidermal growth factor receptor status in operable invasive breast cancer: is it of any prognostic value? (2004) (32)
- Routine audit of breast fine needle aspiration (FNA) cytology specimens and aspirator inadequate rates (1997) (32)
- An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data. (1990) (32)
- Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genes (1996) (32)
- The use of monoclonal antibody 791T/36 in the immunoscintigraphy of primary and metastatic carcinoma of the breast. (1984) (30)
- Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancer. (1989) (30)
- The role of four oestrogen-responsive genes, pLIV1, pS2, pSYD3 and pSYD8, in predicting responsiveness to endocrine therapy in primary breast cancer. (1993) (29)
- Early experience in breast cancer screening: emphasis on development of protocols for triple assessment (1993) (28)
- Endocrine treatment of physiological gynaecomastia (2003) (28)
- Subcutaneous mastectomy with implant reconstruction: cosmetic outcome and patient satisfaction. (2000) (27)
- Influence of anti-oestrogens on the specific binding in vitro of (3H)oestradiol by cytosol of rat mammary tumours and human breast carcinomata. (1975) (27)
- The breast pain clinic: a rational approach to classification and treatment of breast pain. (1987) (27)
- A double‐blind controlled trial of danazol and bromocriptine in the management of severe cyclical breast pain (1986) (26)
- Carcinoembryonic antigen (CEA): its role as a tumour marker in breast cancer. (1981) (25)
- The early results from a randomised study of radiotherapy versus Nolvadex (tamoxifen) as initial treatment for stage III breast cancer. (1988) (25)
- Value of Contralateral Surveillance Mammography for Primary Breast Cancer Follow-up (2000) (25)
- Transforming growth factor-alpha and endocrine sensitivity in breast cancer. (1994) (24)
- Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist D-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancer. (1986) (24)
- Transplantation, immunosuppression and plasmapheresis in Goodpasture's syndrome. (1978) (24)
- A prospective study of patient choice in treatment for primary breast cancer. (1991) (23)
- Effect of human leucocyte antigen matching on the incidence of acute rejection in renal transplantation (1994) (23)
- Zoladex® plus tamoxifen versus zoladex® alone in pre- and peri-menopausal metastatic breast cancer (1990) (23)
- Breast self-examination for the early detection of breast cancer. (1988) (21)
- The management of locally advanced carcinoma of the breast by Nolvadex (tamoxifen): a pilot study. (1984) (21)
- Characteristics of cadaveric renal allograft recipients developing chronic rejection. (1990) (21)
- Phenotypic similarities in bilateral breast cancer (2004) (20)
- MONITORING THE FUNCTION OF RENAL TRANSPLANTS (1977) (20)
- An observation of DNA ploidy, histological grade, and immunoreactivity for tumour‐related antigens in primary and metastatic breast carcinoma (1989) (20)
- Survival data relating to the use of goserelin depot in the treatment of premenopausal advanced breast cancer. (1993) (20)
- Metallothionein expression in human breast cancer (1992) (20)
- The Primary Implantation of Human Tumours to the Hamster Cheek Pouch (1971) (20)
- Reticuloendothelial activity during the growth of rat sarcomas. (1969) (19)
- Clinical Radiology of the Breast (1990) (19)
- Safe selection criteria for breast conservation without radical excision in primary operable invasive breast cancer. (1995) (19)
- Natural killer cells in renal allograft rejection (1984) (19)
- Mammography in the pre-operative assessment and post-operative surveillance of patients treated by excision and radiotherapy for primary breast cancer. (1990) (18)
- MEDICAL RESEARCH COUNCIL TRIAL OF ANTILYMPHOCYTE GLOBULIN IN RENAL TRANSPLANTATION: A MULTICENTER RANDOMIZED DOUBLE‐BLIND PLACEBO CONTROLLED CLINICAL INVESTIGATION (1983) (18)
- Preliminary results of the Nottingham breast self‐examination education programme (1987) (18)
- Identification of a monoclonal antibody-defined breast carcinoma antigen in body fluids. (1987) (18)
- Are backup arteriovenous fistulae necessary for patients on continuous ambulatory peritoneal dialysis? (1993) (18)
- Overexpression of Cyclin D 1 Messenger RNA Predicts for Poor Prognosis in Estrogen Receptor-positive Breast Cancer 1 (1999) (18)
- The relationship of oestradiol receptor (ER) and histological tumour differentiation with prognosis in human primary breast carcinoma. (1980) (17)
- The prediction of local or regional recurrence after simple mastectomy for operable breast cancer (1985) (17)
- INK 4 a Gene Expression and Methylation in Primary Breast Cancer : Overexpression of p 16 INK 4 a Messenger RNA Is a Marker of Poor Prognosis 1 (2000) (16)
- A comparison of danazol and placebo in the treatment of adult idiopathic gynaecomastia: results of a prospective study in 55 patients. (1991) (16)
- Salivary cortisol and dehydroepiandrosterone sulphate levels in postmenopausal women with primary breast cancer. (1983) (15)
- Estimation of Prognosis of the Individual with Primary Breast Cancer and its Applications (2002) (14)
- Cathepsin D in primary breast carcinoma: Adverse prognosis is associated with expression of cathepsin D in stromal cells (2004) (14)
- An evaluation of transmission spectroscopy (lightscanning) in the diagnosis of symptomatic breast lesions. (1987) (14)
- The use of serum carcinoembryonic antigen to assess therapeutic response in locally advanced and metastatic breast cancer: a prospective study with external review. (1988) (14)
- Plasma spermidine concentrations in patients with tumours of the breast or prostate or testis. (1980) (13)
- Patterns of flap recurrence following mastectomy (1985) (13)
- BREAST CANCER, TAMOXIFEN, AND SURGERY (1988) (13)
- Initial results from a programme of breast self-examination. (1983) (13)
- Serum ferritin as a marker of therapeutic response in stage III and IV breast cancer. (1990) (13)
- Mammographic parenchymal patterns: value as a predictor of hormone dependency and survival in breast cancer. (1985) (12)
- ABC of Breast Diseases: Screening for Breast Cancer (1994) (12)
- Spleen Weight in Rats During Tumour Growth and in Homograft Rejection (1971) (11)
- Ductal Carcinoma In-Situ Of The Breast: A new simplified histological classification. Association between cellular proliferation and c-erbB-2 protein expression (1992) (11)
- Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer. (2001) (11)
- The BASO II trial of adjuvant radiotherapy. V. None and tamoxifen. V. None in small, node negative, grade I tumours (2001) (11)
- Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma (1991) (10)
- Review of the endocrine actions of luteinising hormone-releasing hormone analogues in premenopausal women with breast cancer. (1989) (10)
- A controlled trial of danazol in the treatment of multiple recurrent breast cysts (1986) (10)
- Availability of organs for transplantation: a three year study. (1986) (10)
- Characterisation of breast skin temperature rhythms of women in relation to menstrual status. (1981) (10)
- Blood transfusion and renal allograft survival. (1978) (9)
- Therapeutic potential of the lh-rh agonist zoladex (ICI 118630) in the treatment of advanced breast cancer in pre and postmenopausal women (1984) (9)
- Density of lymphocytic infiltration of primary breast cancer does not affect short-term disease-free interval or survival. (1990) (8)
- P107 The ‘ZEBRA’ study: ‘Zoladex’ (goserelin) vs CMF as adjuvant therapy in the management of node positive stage II breast cancer in pre/peri-menopausal women aged 50 years or less (1998) (8)
- The role of selective non-steroidal aromatase inhibitors in future treatment strategies. (1997) (8)
- Tumour epithelial cellularity and quantitative oestrogen receptor values in primary breast cancer. (1983) (8)
- Update of the BASO II trial of primary treatment of tumours of excellent prognosis (2004) (8)
- TRIALS OF ADJUVANT CHEMOTHERAPY IN BREAST CANCER (1979) (8)
- Biological and clinical aspects of oestrogen receptor measurements in rapidly progressing breast cancer (1984) (8)
- PP-3-20 local excision with a 10 mm margin as sole treatment for ductal carcinoma in situ (dcis) of the breast (1996) (8)
- Postoperative radiotherapy following mastectomy for high-risk breast cancer. A randomised trial. (2002) (8)
- Zoladex in advanced breast cancer. (1989) (8)
- Local anaesthetic and steroid combined injection therapy in the management of non-cyclical mastalgia. (2004) (8)
- Mammographic and pathological features of breast cancer detected at first incident round screening (1997) (8)
- Selection of Primary Breast Cancer Patients for Adjuvant Endocrine Therapy – is Oestrogen Receptor Alone Adequate? (2004) (7)
- Selection for adjuvant systemic therapy using the Nottingham prognostic index (NPI) (1993) (7)
- Complications in the management of breast disease (1986) (7)
- Pure antioestrogens in breast cancer - experimental and clinical observations (1994) (7)
- Oestrogen receptors in primary breast cancer. (1985) (7)
- A comparison of fine needle aspiration cytology and tru-cut tissue biopsy in the diagnosis of acute renal allograft rejection. (1986) (7)
- The use of 125 I-fibrinogen in the detection of renal allograft rejection. Rat model. (1973) (6)
- Micrometastases in bone marrow in patients with breast cancer. (1987) (6)
- Evaluation of animal models of chronic vascular rejection. (1993) (6)
- A suggested classification of breast pain. (1979) (6)
- Experiments in tumour immunology (1968) (6)
- Prolactin and breast skin temperature rhythms in postmenopausal women with primary breast cancer. (1983) (6)
- OBSERVATIONS ON THE REMOVAL OF CELLS AND PARTICIPATE MATTER FROM THE HAMSTER CHEEK POUCH (1968) (6)
- A simple index to predict prognosis independent of axillary node information in breast cancer: comment. (1998) (6)
- Diagnosis by team work: an approach to conservatism. (1991) (6)
- The role of the radiologist in breast diagnosis: a surgeon's personal view. (1998) (6)
- The effect of isogenic lymphoid cell on primary sarcomas in the rat. (1969) (6)
- Node negative breast cancer. (1990) (5)
- Phenotypic drift does not happen but lots of interesting things do (1993) (5)
- 86. Pharmacokinetics, systemic and antitumour effects of the specific antioestrogen ICI 182780 in women with advanced breast cancer (1995) (5)
- Clinical studies with the specific ‘pure’ antioestrogen ICI 182780 (1996) (5)
- Bilateral breast carcinomas: do they have similar mammographic features? (1999) (5)
- Post-mastectomy radiotherapy in patients at high risk of locoregional recurrence: A randomized trial (1992) (5)
- Should women be advised to take prophylactic endocrine treatment outside of a clinical trial setting? (2005) (4)
- The 1989 Walter Hubert lecture. Does biological understanding influence surgical practice? (1989) (4)
- B.I.G.--brother is watching you? (2000) (4)
- Long-term follow up of patients treated with a single course of danazol for recurrent breast cysts. (1989) (4)
- Renal allotransplantation in the rat: method and histological findings. (1974) (4)
- A comparison of the characteristics and prognosis of screen detected and symptomatic breast cancers (1993) (4)
- EUSOMA guidelines on the management of familial breast cancer risk (2004) (4)
- Season of initial detection in breast cancer. (1991) (4)
- Relation of mastalgia to breast cancer (1982) (4)
- Differential expression of estrogen-regulated genes in breast-cancer (1995) (4)
- Place and training of the surgeon in breast cancer screening. (1989) (4)
- Management of primary breast cancer in the elderly patient. (2003) (3)
- Breast transillumination using the sinus diaphanograph. (1981) (3)
- Cathepsin D reactivity in human breast carcinoma. Important prognostic factor or epiphenomenon (1992) (3)
- The use of DNA typing to clarify the origin of metastatic carcinoma after renal transplantation (1994) (3)
- Comments on NCI Alert on node-negative breast cancer (1989) (3)
- The Nottingham Research Programme in breast cancer. (1984) (3)
- The effect of some stilboestrol compounds on deoxyribonucleic acid polymerase from human and canine prostatic tissue. (1969) (3)
- The diagnosis and prognosis of breast cancer. (1982) (3)
- The Nottingham breast self-examination project. (1989) (3)
- The use of the pelvic radiograph alone to assess therapeutic response in bone metastases from breast cancer. (1988) (3)
- Results from a seven-year programme of breast self-examination in 89,010 women (1990) (3)
- Tests of cell mediated immunity in patients with early breast cancer. I. Response to DNCB at time of mastectomy. (1978) (2)
- The relationship of background mammographic pattern to hormone dependency in breast cancer (1984) (2)
- O-62 External validation in ONCOPOOL of updated survival according to the Nottingham Prognostic Index (NPI) (2007) (2)
- Steroid Receptors and Primary Breast Cancer: Their Prognostic Value (1984) (2)
- Randomised trial comparing zoladex∗ with nolvadex∗ plus zoladex in pre-menopausal advanced breast cancer (1992) (2)
- RECRUITMENT TO BREAST CANCER TRIALS (1984) (2)
- 98. Mammographic features of interval cancers and prognosis compared with screen detected and symptomatic breast cancers (1995) (2)
- O-46 The prognosis of small breast cancers and selection for omission of adjuvant chemotherapy (2007) (2)
- 115 HER2 (cerbB2) positivity: cross correlations, and effect on survival of a pre-Herceptin treated group (2010) (2)
- Mastectomy or conservation: the patient's choice. (1988) (2)
- Availability of Organs for Transplantation: A Three Year Study (1987) (2)
- The introduction of the LHRH agonist, Goserelin (Zoladex) into clinical practice (1997) (2)
- Drugs for breast pain. (1981) (2)
- The problems referred to a breast clinic. (1988) (2)
- MANAGEMENT OF INTRA-DUCT CARCINOMA (1984) (2)
- Comment on ‘Predicting recurrence in axillary node negative breast cancer patients’, by Rosner and Lane (1993) (2)
- Advances in the management of metastatic bone disease (1994) (2)
- DNA fingerprinting of benign and malignant breast lesions. (1996) (2)
- Flap recurrence following simple mastectomy: an audit (1993) (2)
- Localization of incompetent perforating vei by thermography. (1969) (1)
- O-59 Identification of sub-classes of breast cancer through consensus derived from automated clustering methods (2007) (1)
- Are you a typer, grader or a molecular convert? Prognostic assessment of operable breast carcinoma (1992) (1)
- Oestrogen receptor content of primary breast tumours as a prognostic indicator of early recurrence [proceedings]. (1978) (1)
- Drugs for breast pain. (1981) (1)
- 33. Small breast cancer: an integrated index is still important (1995) (1)
- Value of breast imaging in women with painful breasts. Women with severe problems must be seen in specialist breast clinics. (1999) (1)
- Atlas of breast cancer (1994) (1)
- Age is not an independent prognostic factor (2001) (1)
- Selective use of post-mastectomy flap irradiation in high-risk breast cancer patients. (2005) (1)
- Epidermal Growth Factor Receptor (EGFR) expression: Prognostic value in breast cancer patients with long-term follow-up (2001) (1)
- Higher degrees in surgical training a pre‐meeting workshop at the Surgical Research Society (1984) (1)
- Proceedings: Primary breast cancer: identification of poor prognosis. (1976) (1)
- Treatment of poor prognosis renal allograft rejection with anti-lymphocyte globulin (ALG) ― An analysis of late results (1988) (1)
- Flow and static cytometry in the automated analysis of grading in breast cancer (1992) (1)
- Measurement of the immune response to an allograft: Amino acid incorporation by peripheral white blood cells in man (1975) (1)
- Results of first line endocrine therapy for advanced breast cancer in premenopausal women with skeletal metastases only (1993) (1)
- Major problems in pathology volume II: Problems in breast pathology. J. G. Azzopardi. 268×188 mm. Pp. 466+xvi. Illustrated. 1979. Eastbourne: Saunders. £25·00. (1982) (1)
- Improvement in HLA matching and graft survival achieved by organ sharing. (1991) (1)
- 2 Markers for diagnosis (1995) (1)
- 78. Subcutaneous mastectomy for primary breast cancer or ductal carcinoma in situ (1995) (1)
- Surgery versus tamoxifen in selected elderly patients with operable breast cancer: Early results of a randomised trial (1992) (1)
- The rates of growth of breast cancers (2004) (1)
- The BASO II trial of primary treatment of tumours of excellent prognosis (2006) (1)
- The Feulgen hydrolysis profile and breast carcinoma: a preliminary study. (1988) (1)
- 19. Selection criteria for breast conservation in primary operable invasive breast cancer (1995) (1)
- Corrigendum to “ONCOPOOL – A European database for 16,944 cases of breast cancer” [European Journal of Cancer 46 (2009) 56–71] (2010) (1)
- Tables of anticipated benefit from adjuvant therapy for the individual (2001) (1)
- Breast cancer screening: A benefit can be anticipated (1992) (1)
- Multimodal treatment in operable breast cancer (1983) (1)
- Non-operative management of discrete palpable breast lumps in women over 35 years of age (1992) (1)
- Factors underlying the improvement in mortality from breast cancer (2001) (1)
- Effect of acute damage from acute rejection and ischemia on long-term renal allograft histology. (1993) (1)
- Histological grade in predicting response to endocrine treatment (2005) (1)
- Frequency of screening for breast cancer (1989) (1)
- Safe criteria for breast conservation without radical excision (1993) (1)
- OUTCOME INDICATORS FOR BREAST CANCER (1999) (1)
- Randomised clinical trials in breast cancer (1992) (1)
- Non-operation of discrete solid palpable breast lumps in women over 35 years of age is safe (1993) (0)
- Mammographic screening for breast cancer. Significant reduction in recall and benign biopsy rates associated with the introduction of set management policies (1992) (0)
- P163 The prognosis of small breast cancers (2007) (0)
- Book Review: Access Surgery: A Review of Current Techniques for Vascular Access for Haemodialysis, Chemotherapy and Total Parenteral Nutrition (1983) (0)
- 35. Comparability of prognostic indices (1995) (0)
- Primary management of breast cancer: Alternatives to mastectomy. J. S. Tobias and M. J. Peckham. 240 × 160 mm. Pp. 220 + xvii. Illustrated in black and white. 1985. London: Edward Arnold Ltd. £32.50 (1986) (0)
- O-9 ONCOPOOL – A European Database in 16,893 cases of breast cancer: comparison with SEER (2007) (0)
- Reticulo‐endothelial system activity during homograft rejection and immunosuppression (1972) (0)
- Reply to Editorial Comment (2002) (0)
- 1039 Post-mastectomy radiotherapy (RT) in high-risk patients (1995) (0)
- Can sentinel node biopsy improve prognostic discrimination (2002) (0)
- Proceedings: Renal and skin allograft rejection in presensitized animals. (1974) (0)
- DNA ploidy in fibroadenomas (abstract). (1989) (0)
- Breast cancer screening: counter editorial. (1989) (0)
- theimportanceof chronic rejection as a cause of gra t loss (1989) (0)
- Transabdominal bilateral adrenalectomy for metastatic breast cancer. (1980) (0)
- Author's response: Reply from Professor R. W. Blamey (1985) (0)
- Author Index/Subject Index (2020) (0)
- Invasive micropapillary carcinoma of the breast (2000) (0)
- O-63 Survival in East Anglia according to the Nottingham Prognostic Index (2007) (0)
- re: Family history screening and breast cancer (1997) (0)
- Points: Urological complications of renal transplantation (1982) (0)
- The effect on survival of local recurrence (LR) after breast conserving surgery (2006) (0)
- O-20 Rates of growth of breast cancer (2010) (0)
- Investigation of a novel pure antioestrogen in women with primary breast cancer (1993) (0)
- Epidermal Growth Factor Receptor Status in Operable Invasive Breast Cancer (2004) (0)
- O-3 Long-term results from the ZEBRA trial comparing Goserelin with CMF as adjuvant therapy in premenopausal women (2007) (0)
- LH-RH Agonists for the Treatment of Breast Cancer (2009) (0)
- BREAST RECONSTRUCTION AFTER SUBCUTANEOUS MASTECTOMY (1979) (0)
- The genetic fingerprinting of breast cancers (1992) (0)
- HISTOLOGICAL GRADE AND RESPONSE TO ENDOCRINE THERAPY IN BREAST CANCER (1981) (0)
- Morbidity from lymphoedema following treatment of primary breast cancer (2003) (0)
- Screening for contralateral breast cancer — is it worthwhile? (1993) (0)
- Phyllodes tumors of the breast histological features and clinical behavior (1991) (0)
- Axillary lymph node metastases from clinically occult breast carcinoma. (1987) (0)
- Post-mastectomy reconstruction. T. D. Gant and L. O. Vasconez. 260 × 175 mm. Pp. 179 + x. Illustrated. 1981. Baltimore: Williams & Wilkins (1981) (0)
- Contents, Supplement 2, 1997 (1997) (0)
- Single duct discharge from the nipple (1989) (0)
- Measurement of lymphocyte activity in response to a renal allograft. (1973) (0)
- Discussion paper — sentinel node biopsy: Hope or hype? (2001) (0)
- Roger Ernest Cotton (2006) (0)
- 60. Radiotherapy may be unnecessary after adequate local excision of ductal carcinoma in situ (1995) (0)
- Fulvestrant: A Viewpoint by Roger W. Blamey (2001) (0)
- Hormonochemotherapy in advanced breast cancer (1987) (0)
- The silent majority — meeting the emotional needs of women with a negative diagnosis — the results of a patient survey (1993) (0)
- Breast screening in Scandinavia (1990) (0)
- O-72 Remodeling the Nottingham Prognostic Index (NPI) for individual prognosis (2010) (0)
- D-1 Absolute Gain (2007) (0)
- 54. The assessment of multiple variables on preoperative opeast carcinoma fine needle aspiration cytology specimens (1995) (0)
- Where Bench and Field Sciences Meet: Molecular Epidemiology at NIEHS (1994) (0)
- Breast cancer. The facts. Michael Baum. 223 × 140 mm. Pp. 111 + ix. Illustrated. 1981. Oxford: Oxford Univ. Press. £4.95 (1983) (0)
- Prognostic value of immunocytochemistry of the primary tumour in patients with metastatic breast cancer (1995) (0)
- Proceedings: Lymphocyte capacity and lymphoblast circulation in immune stimulation and immunosuppression. (1976) (0)
- erbB Signalling in breast cancer (2007) (0)
- The ZEBRA study: Zoladex™ is as effective as CMF in pre-/perimenopausal patients with oestrogen receptor positive, node-positive early breast cancer (2001) (0)
- 0-41. An update on breast screening for women aged < 50: results from a family history clinic (1997) (0)
- O-105 erbB Signalling in breast cancer (2007) (0)
- Screening the at risk patient: family history (1993) (0)
- 9 The initial approach to tumour markers in guiding therapy (1995) (0)
- DNA ploidy and proliferative index in breast cancer prognosis (1992) (0)
- Correspondence (1979) (0)
- Prediction of survival in the individual with breast cancer. (1999) (0)
- O-71 Rescoring of grade and re-evaluation of the Nottingham Prognostic Index (NPI) using components of Elston Ellis grade and adding lympho-vascular invasion (2010) (0)
- Reading the prognosis of the individual according to the exact NPI value (2004) (0)
- Comment on ‘New lumps in the breast following conservation treatment for early breast cancer’ (1988) (0)
- Measurement of the immune response to a renal allograft. I. Evaluation of changes in lymphocyte activity in the rat. (1973) (0)
- 0-59. The National health service breast screening programme in the trent region — are we meeting the targets? (1997) (0)
- A REVIEW FROM THE BRITISH ASSOCIATION OF SURGICAL ONCOLOGY (1999) (0)
- PP-6-7 Automated grading in a prognostic index (1996) (0)
- 146 ONCOPOOL, a comparison with SEER (2010) (0)
- Generic substitution (1983) (0)
- Survey of patient opinion on the retrospective use of their tissues for research (2004) (0)
- AVAILABILITY OF KIDNEY DONORS IN THE TRENT REGION (1981) (0)
- Representation of hospital junior doctors (1969) (0)
- PP-6-6 The Prognostic Importance of Tumour Grade in Lymph Node Positive Breast Cancer (1996) (0)
- The frequency of breast cancer screening: results of a randomised trial (2004) (0)
- An Inexpensive Zoom Double Operating Microscope System (1977) (0)
- Therapeutic Aspects of Screen-Detected Lesions: The Role of the Surgeon (1993) (0)
- ONCOPOOL — A European dataset in 16,893 cases of breast cancer (2006) (0)
- Confirmation of a prognostic index for breast cancer (1992) (0)
- 51. Angiogenesis in human breast carcinoma (1995) (0)
- A computer programme to calculate for the individual the expected improvement in survival chance from adjuvant therapies (2004) (0)
- The prognostic significance of inflammation in invasive carcinoma of the breast (2006) (0)
- Marker biopsy of 268 impalpable breast lesions: An audit of the radiological, pathological and surgical aspects (1992) (0)
- Metallothionein expression inhumanbreast cancer (1995) (0)
- Reticulo-endothelial system (R.E.S.) activity during immunosuppression. (1968) (0)
- cancer ABC of breast diseases : Screening for breast (2000) (0)
- A Clinical Database for the Study op Prognostic Factors in Breast Cancer (1985) (0)
- Comment on prognosis in node negative breast cancer (1987) (0)
- Breast Disease is now a Specialist Discipline (2006) (0)
- Influence ofAnti-Oestrogens ontheSpecific Binding invitro ofL3HlOestradiol by Cytosol ofRatMammaryTumours andHumanBreast Carcinomata (1975) (0)
- Basic and clinical immunology. Edited H. H. Fudenberg, D. P. Stites, J. L. Caldwell and J. V. Wells. Second edition. 255 × 180 mm. Pp. 758. Illustrated. 1978. California: Lange. $14.50 (1979) (0)
- Combination chemotherapy in breast cancer: response rate and attempts to predict response. (1979) (0)
- E3. The impact of surgical techniques on quality of life (2002) (0)
- Sentinel node biopsy versus axillary node sampling in axillary staging (1999) (0)
- The effect of screening on mortality (2004) (0)
- Further comment on ‘complete response’ in breast cancer treatment (1986) (0)
- Updated survival analyses from the ZEBRA study: goserelin vs CMF in premenopausal women with node-positive breast cancer (2003) (0)
- O-68 The effect of lymphovascular invasion (LVI) on survival (2010) (0)
- The formation of membrane-bound glycoproteins by explants of malignant human breasttissue (1984) (0)
- Atlas of Breast Pathology. Folke Linell and Otto Ljungberg. 250 ± 175 mm. Pp. 305. Illustrated in black and white and colour. 1984. Copenhagen: Munksgaard Internat. 570.00 D.kr. (1985) (0)
- Zoladex plus tamoxifen versus zoladex alone in premenopausal metastatic breast cancer (1990) (0)
- The short-term effects of cadaveric kidney exchange via a beneficial matching scheme. (1991) (0)
- The operative management of breast disease R. R. Baker and J. Niederhuber. 285 × 220 mm. Pp. 135. Illustrated. 1992. Philadelphia, Pennsylvania: W. B. Saunders. £83 (1993) (0)
- The Nottingham proceedings : selected papers from the Nottingham International Breast Cancer Meeting, September 1990 (1991) (0)
- Localization of incompetent veins by thermography. (1969) (0)
- Pinning down the diagnosis in breast cancer. (1977) (0)
- Seventeenth Sir Peter Freyer memorial lecture and surgical symposium (1994) (0)
- O-47 The BASO II trial at median 15 years of follow-up (2010) (0)
- TRAFFIC OF LYMPHOCYTES IN THE THORACIC DUCT AND RENAL LYMPH AFTER ALLOTRANSPLANTATION AND IN IMMUNOSUPPRESSION (1978) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Roger W. Blamey?
Roger W. Blamey is affiliated with the following schools: